Back to Search
Start Over
Efavirenz, atazanavir, and ritonavir disrupt sarcoplasmic reticulum Ca 2+ homeostasis in skeletal muscles.
- Source :
-
Antiviral research [Antiviral Res] 2021 Mar; Vol. 187, pp. 104975. Date of Electronic Publication: 2021 Jan 13. - Publication Year :
- 2021
-
Abstract
- While muscle fatigue, pain and weakness are common co-morbidities in HIV-1 infected people, their underlying cause remain poorly defined. To this end, we evaluated whether the common antiretroviral drugs efavirenz (EFV), atazanavir (ATV) and ritonavir (RTV) could be a contributing factor by pertubating sarcoplasmic reticulum (SR) Ca <superscript>2+</superscript> cycling. In live-cell imaging, EFV (6.0 μM), ATV (6.0 μM), and RTV (3.0 μM) elicited Ca <superscript>2+</superscript> transients and blebbing of the plasma membranes of C2C12 skeletal muscle myotubes. Pretreating C2C12 skeletal muscle myotubes with the SR Ca <superscript>2+</superscript> release channel blocker ryanodine (50 μM), slowed the rate and amplitude of Ca <superscript>2+</superscript> release from and reuptake of Ca <superscript>2+</superscript> into the SR. EFV, ATV and RTV (1 nM - 20 μM) potentiated and then displaced [ <superscript>3</superscript> H] ryanodine binding to rabbit skeletal muscle ryanodine receptor Ca <superscript>2+</superscript> release channel (RyR1). These drugs at concentrations 0.25-31.2 μM also increased and or decreased the open probability of RyR1 by altering its gating and conductance. ATV (≤5 μM) potentiated and >5μM inhibited the ability of sarco (endo)plasmic reticulum Ca <superscript>2+</superscript> -ATPase (SERCA1) to hydrolyze ATP and transport Ca <superscript>2+</superscript> . RTV (2.5-31.5 μM) dose-dependently inhibited SERCA1-mediated, ATP-dependent Ca <superscript>2+</superscript> transport. EFV (0.25-31.5 μM) had no measurable effect on SERCA1's ability to hydrolyze ATP and transport Ca <superscript>2+</superscript> . These data support the notion that EFV, ATV and RTV could be contributing to skeletal muscle co-morbidities in PLWH by modulating SR Ca <superscript>2+</superscript> homeostasis.<br /> (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Subjects :
- Alkynes adverse effects
Animals
Atazanavir Sulfate adverse effects
Benzoxazines adverse effects
Cell Line
Cyclopropanes adverse effects
Homeostasis
Mice
Myoblasts drug effects
Rabbits
Ritonavir adverse effects
Ryanodine pharmacology
Sarcoplasmic Reticulum metabolism
Time-Lapse Imaging
Anti-HIV Agents adverse effects
Calcium metabolism
Muscle, Skeletal drug effects
Ryanodine Receptor Calcium Release Channel metabolism
Sarcoplasmic Reticulum drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1872-9096
- Volume :
- 187
- Database :
- MEDLINE
- Journal :
- Antiviral research
- Publication Type :
- Academic Journal
- Accession number :
- 33450312
- Full Text :
- https://doi.org/10.1016/j.antiviral.2020.104975